Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human prothrombin complex concentrate in hemophilia B
CTR20140124Phase 3Active
- Sponsor
- Harbin Shiheng Bioengineering Pharmaceutical
- Start
- Apr 2014
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Harbin Shiheng Bioengineering Pharmaceutical. Started Apr 2014; status: active.
02
Drugs
balfaxar
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20140124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140124.